These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 8539772

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.
    Stittelaar KJ, de Swart RL, Vos HW, van Amerongen G, Agafonov AP, Nechaeva EA, Osterhaus AD.
    Vaccine; 2002 Jul 26; 20(23-24):2906-12. PubMed ID: 12126901
    [Abstract] [Full Text] [Related]

  • 23. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [Abstract] [Full Text] [Related]

  • 24. Predicting and comparing long-term measles antibody profiles of different immunization policies.
    Lee MS, Nokes DJ.
    Bull World Health Organ; 2001 May 01; 79(7):615-24. PubMed ID: 11477964
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Active measles vaccination contraindicated during the incubation period?].
    Vivell O.
    Med Klin; 1972 Sep 29; 67(39):1263. PubMed ID: 4639566
    [No Abstract] [Full Text] [Related]

  • 27. Optimum age of measles immunization--maternal and transplacentally transmitted measles antibodies in infancy.
    Mohan M, Mehta PK, Sehgal S, Prabhakar AK, Bhargava SK.
    Indian Pediatr; 1981 Sep 29; 18(9):631-5. PubMed ID: 7319611
    [No Abstract] [Full Text] [Related]

  • 28. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
    Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ.
    J Virol; 2006 Sep 29; 80(17):8530-40. PubMed ID: 16912303
    [Abstract] [Full Text] [Related]

  • 29. Effect of immunosuppression on morphological changes in CNS of monkeys infected with different measles virus vaccine strains.
    Sharova OK, Rozina EE, Gordienko NM, Shteinberg LS.
    Acta Virol; 1984 Mar 29; 28(2):144-7. PubMed ID: 6145348
    [Abstract] [Full Text] [Related]

  • 30. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ, Doblas D, Andrews N.
    Vaccine; 2008 Nov 25; 26(50):6392-7. PubMed ID: 18834911
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characteristics of measles antibodies in premature infants: Comment.
    Daungsupawong H, Wiwanitkit V.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2352279. PubMed ID: 38754017
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Persistence of antibodies for measles among vaccinated medical students in Italy.
    Coppeta L, Somma G, Di Giampaolo L, Bizzarro G, Ippoliti L, Borelli F, Balbi O, Perrone S, Pietroiusti A.
    Infect Dis (Lond); 2020 Aug 31; 52(8):593-595. PubMed ID: 32484374
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection.
    Brunell PA, Vimal V, Sandu M, Courville TM, Daar E, Israele V.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec 15; 10(5):540-8. PubMed ID: 8548333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.